Gene Activity List

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 5 of 1714:
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Gene Compound Assay Inh Ic50 Ki View
sodium channel, voltage-gated, type IV, alpha polypeptide MIFEPRISTONE Sodium Channel, Site 2 100% 5.922uM 5.31uM View
sodium channel, voltage-gated, type V, alpha polypeptide MIFEPRISTONE Sodium Channel, Site 2 100% 5.922uM 5.31uM View
sodium channel, voltage-gated, type II, beta MIFEPRISTONE Sodium Channel, Site 2 100% 5.922uM 5.31uM View
sodium channel, nonvoltage-gated 1 alpha MIFEPRISTONE Sodium Channel, Site 2 100% 5.922uM 5.31uM View
sodium channel, nonvoltage-gated 1 gamma MIFEPRISTONE Sodium Channel, Site 2 100% 5.922uM 5.31uM View
sodium channel, nonvoltage-gated 1 beta MIFEPRISTONE Sodium Channel, Site 2 100% 5.922uM 5.31uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide MIFEPRISTONE Sodium Channel, Site 2 100% 5.922uM 5.31uM View
sodium channel, voltage-gated, type XI, alpha MIFEPRISTONE Sodium Channel, Site 2 100% 5.922uM 5.31uM View
sodium channel, nonvoltage-gated 1, gamma MIFEPRISTONE Sodium Channel, Site 2 100% 5.922uM 5.31uM View
sodium channel, nonvoltage-gated 1, delta MIFEPRISTONE Sodium Channel, Site 2 100% 5.922uM 5.31uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) MIFEPRISTONE Sodium Channel, Site 2 100% 5.922uM 5.31uM View
sodium channel, nonvoltage-gated 1 alpha MIFEPRISTONE Sodium Channel, Site 2 100% 5.922uM 5.31uM View
sodium channel, voltage-gated, type X, alpha MIFEPRISTONE Sodium Channel, Site 2 100% 5.922uM 5.31uM View
sodium channel, voltage-gated, type IX, alpha MIFEPRISTONE Sodium Channel, Site 2 100% 5.922uM 5.31uM View
sodium channel, voltage gated, type VIII, alpha MIFEPRISTONE Sodium Channel, Site 2 100% 5.922uM 5.31uM View
sodium channel, voltage-gated, type VII, alpha MIFEPRISTONE Sodium Channel, Site 2 100% 5.922uM 5.31uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) MIFEPRISTONE Sodium Channel, Site 2 100% 5.922uM 5.31uM View
sodium channel, voltage-gated, type IV, beta MIFEPRISTONE Sodium Channel, Site 2 100% 5.922uM 5.31uM View
sodium channel, voltage-gated, type IV, alpha MIFEPRISTONE Sodium Channel, Site 2 100% 5.922uM 5.31uM View
sodium channel, voltage-gated, type III, alpha MIFEPRISTONE Sodium Channel, Site 2 100% 5.922uM 5.31uM View
sodium channel, voltage-gated, type II, beta MIFEPRISTONE Sodium Channel, Site 2 100% 5.922uM 5.31uM View
sodium channel, voltage-gated, type II, alpha 2 MIFEPRISTONE Sodium Channel, Site 2 100% 5.922uM 5.31uM View
sodium channel, voltage-gated, type I, beta MIFEPRISTONE Sodium Channel, Site 2 100% 5.922uM 5.31uM View
sodium channel, voltage-gated, type I, alpha MIFEPRISTONE Sodium Channel, Site 2 100% 5.922uM 5.31uM View
estrogen receptor 1 DIETHYLSTILBESTROL Estrogen ERalpha 100% .000915uM .000261uM View
estrogen receptor 1 DIETHYLSTILBESTROL Estrogen ERalpha 100% .000915uM .000261uM View
nuclear receptor subfamily 3, group C, member 1 MIFEPRISTONE Glucocorticoid 100% .002232uM .001014uM View
prostaglandin-endoperoxide synthase 1 DIETHYLSTILBESTROL Cyclooxygenase COX-1 100% 5.6uM NoneNone View
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) DIETHYLSTILBESTROL Cyclooxygenase COX-1 100% 5.6uM NoneNone View
Cytochrom P450-1A2 monooxygenase LY-294002 CYP450-1A2 Inhibition 100% 1uM NoneNone View
tachykinin receptor 2 DIETHYLSTILBESTROL Tachykinin NK2 100% 9.553uM 3.184uM View
opioid receptor, delta 1 DIETHYLSTILBESTROL Opiate delta 100% 2.718uM .958uM View
sodium channel, voltage-gated, type IV, beta DANAZOL Sodium Channel, Site 2 100% 2.978uM 2.67uM View
sodium channel associated protein 1 DANAZOL Sodium Channel, Site 2 100% 2.978uM 2.67uM View
sodium channel associated protein 2 DANAZOL Sodium Channel, Site 2 100% 2.978uM 2.67uM View
sodium channel, voltage-gated, type III, beta DANAZOL Sodium Channel, Site 2 100% 2.978uM 2.67uM View
sodium channel, voltage-gated, type I, alpha DANAZOL Sodium Channel, Site 2 100% 2.978uM 2.67uM View
sodium channel, voltage-gated, type IX, alpha DANAZOL Sodium Channel, Site 2 100% 2.978uM 2.67uM View
sodium channel, voltage-gated, type VII, alpha DANAZOL Sodium Channel, Site 2 100% 2.978uM 2.67uM View
amiloride-sensitive cation channel 5, intestinal DANAZOL Sodium Channel, Site 2 100% 2.978uM 2.67uM View
sodium channel, voltage-gated, type III, beta DANAZOL Sodium Channel, Site 2 100% 2.978uM 2.67uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide DANAZOL Sodium Channel, Site 2 100% 2.978uM 2.67uM View
sodium channel, voltage-gated, type XI, alpha DANAZOL Sodium Channel, Site 2 100% 2.978uM 2.67uM View
sodium channel, voltage-gated, type I, beta DANAZOL Sodium Channel, Site 2 100% 2.978uM 2.67uM View
sodium channel, voltage-gated, type 10, alpha polypeptide DANAZOL Sodium Channel, Site 2 100% 2.978uM 2.67uM View
sodium channel, voltage-gated, type IV, alpha polypeptide DANAZOL Sodium Channel, Site 2 100% 2.978uM 2.67uM View
sodium channel, voltage-gated, type V, alpha polypeptide DANAZOL Sodium Channel, Site 2 100% 2.978uM 2.67uM View
sodium channel, voltage-gated, type II, beta DANAZOL Sodium Channel, Site 2 100% 2.978uM 2.67uM View
sodium channel, nonvoltage-gated 1 alpha DANAZOL Sodium Channel, Site 2 100% 2.978uM 2.67uM View
sodium channel, nonvoltage-gated 1 gamma DANAZOL Sodium Channel, Site 2 100% 2.978uM 2.67uM View
sodium channel, nonvoltage-gated 1 beta DANAZOL Sodium Channel, Site 2 100% 2.978uM 2.67uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide DANAZOL Sodium Channel, Site 2 100% 2.978uM 2.67uM View
sodium channel, voltage-gated, type XI, alpha DANAZOL Sodium Channel, Site 2 100% 2.978uM 2.67uM View
sodium channel, nonvoltage-gated 1, gamma DANAZOL Sodium Channel, Site 2 100% 2.978uM 2.67uM View
sodium channel, nonvoltage-gated 1, delta DANAZOL Sodium Channel, Site 2 100% 2.978uM 2.67uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) DANAZOL Sodium Channel, Site 2 100% 2.978uM 2.67uM View
sodium channel, nonvoltage-gated 1 alpha DANAZOL Sodium Channel, Site 2 100% 2.978uM 2.67uM View
sodium channel, voltage-gated, type X, alpha DANAZOL Sodium Channel, Site 2 100% 2.978uM 2.67uM View
sodium channel, voltage-gated, type IX, alpha DANAZOL Sodium Channel, Site 2 100% 2.978uM 2.67uM View
sodium channel, voltage gated, type VIII, alpha DANAZOL Sodium Channel, Site 2 100% 2.978uM 2.67uM View
estrogen receptor 1 BETA-ESTRADIOL Estrogen ERalpha 100% .001607uM .000459uM View
estrogen receptor 1 BETA-ESTRADIOL Estrogen ERalpha 100% .001607uM .000459uM View
androgen receptor ETHINYLESTRADIOL Testosterone 100% 1.634uM 1.09uM View
androgen receptor MIFEPRISTONE Testosterone 100% .008345uM .005563uM View
Cytochrom P450-1A2 monooxygenase THIABENDAZOLE CYP450-1A2 Inhibition 100% .8uM NoneNone View
sodium channel, voltage-gated, type IV, beta MIFEPRISTONE Sodium Channel, Site 2 100% 5.922uM 5.31uM View
sodium channel associated protein 1 MIFEPRISTONE Sodium Channel, Site 2 100% 5.922uM 5.31uM View
sodium channel associated protein 2 MIFEPRISTONE Sodium Channel, Site 2 100% 5.922uM 5.31uM View
sodium channel, voltage-gated, type III, beta MIFEPRISTONE Sodium Channel, Site 2 100% 5.922uM 5.31uM View
sodium channel, voltage-gated, type I, alpha MIFEPRISTONE Sodium Channel, Site 2 100% 5.922uM 5.31uM View
sodium channel, voltage-gated, type IX, alpha MIFEPRISTONE Sodium Channel, Site 2 100% 5.922uM 5.31uM View
sodium channel, voltage-gated, type VII, alpha MIFEPRISTONE Sodium Channel, Site 2 100% 5.922uM 5.31uM View
amiloride-sensitive cation channel 5, intestinal MIFEPRISTONE Sodium Channel, Site 2 100% 5.922uM 5.31uM View
sodium channel, voltage-gated, type III, beta MIFEPRISTONE Sodium Channel, Site 2 100% 5.922uM 5.31uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide MIFEPRISTONE Sodium Channel, Site 2 100% 5.922uM 5.31uM View
sodium channel, voltage-gated, type XI, alpha MIFEPRISTONE Sodium Channel, Site 2 100% 5.922uM 5.31uM View
sodium channel, voltage-gated, type I, beta MIFEPRISTONE Sodium Channel, Site 2 100% 5.922uM 5.31uM View
sodium channel, voltage-gated, type 10, alpha polypeptide MIFEPRISTONE Sodium Channel, Site 2 100% 5.922uM 5.31uM View
sodium channel, voltage-gated, type V, alpha polypeptide TIRILAZAD Sodium Channel, Site 2 100% 1.359uM 1.219uM View
sodium channel, voltage-gated, type II, beta TIRILAZAD Sodium Channel, Site 2 100% 1.359uM 1.219uM View
sodium channel, nonvoltage-gated 1 alpha TIRILAZAD Sodium Channel, Site 2 100% 1.359uM 1.219uM View
sodium channel, nonvoltage-gated 1 gamma TIRILAZAD Sodium Channel, Site 2 100% 1.359uM 1.219uM View
sodium channel, nonvoltage-gated 1 beta TIRILAZAD Sodium Channel, Site 2 100% 1.359uM 1.219uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide TIRILAZAD Sodium Channel, Site 2 100% 1.359uM 1.219uM View
sodium channel, voltage-gated, type XI, alpha TIRILAZAD Sodium Channel, Site 2 100% 1.359uM 1.219uM View
sodium channel, nonvoltage-gated 1, gamma TIRILAZAD Sodium Channel, Site 2 100% 1.359uM 1.219uM View
sodium channel, nonvoltage-gated 1, delta TIRILAZAD Sodium Channel, Site 2 100% 1.359uM 1.219uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) TIRILAZAD Sodium Channel, Site 2 100% 1.359uM 1.219uM View
sodium channel, nonvoltage-gated 1 alpha TIRILAZAD Sodium Channel, Site 2 100% 1.359uM 1.219uM View
sodium channel, voltage-gated, type X, alpha TIRILAZAD Sodium Channel, Site 2 100% 1.359uM 1.219uM View
sodium channel, voltage-gated, type IX, alpha TIRILAZAD Sodium Channel, Site 2 100% 1.359uM 1.219uM View
sodium channel, voltage gated, type VIII, alpha TIRILAZAD Sodium Channel, Site 2 100% 1.359uM 1.219uM View
sodium channel, voltage-gated, type VII, alpha TIRILAZAD Sodium Channel, Site 2 100% 1.359uM 1.219uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) TIRILAZAD Sodium Channel, Site 2 100% 1.359uM 1.219uM View
sodium channel, voltage-gated, type IV, beta TIRILAZAD Sodium Channel, Site 2 100% 1.359uM 1.219uM View
sodium channel, voltage-gated, type IV, alpha TIRILAZAD Sodium Channel, Site 2 100% 1.359uM 1.219uM View
sodium channel, voltage-gated, type III, alpha TIRILAZAD Sodium Channel, Site 2 100% 1.359uM 1.219uM View
sodium channel, voltage-gated, type II, beta TIRILAZAD Sodium Channel, Site 2 100% 1.359uM 1.219uM View
sodium channel, voltage-gated, type II, alpha 2 TIRILAZAD Sodium Channel, Site 2 100% 1.359uM 1.219uM View
sodium channel, voltage-gated, type I, beta TIRILAZAD Sodium Channel, Site 2 100% 1.359uM 1.219uM View
sodium channel, voltage-gated, type I, alpha TIRILAZAD Sodium Channel, Site 2 100% 1.359uM 1.219uM View
tachykinin receptor 2 CYCLOSPORIN A Tachykinin NK2 100% 4.139uM 1.38uM View
3-hydroxy-3-methylglutaryl-Coenzyme A reductase CERIVASTATIN HMG-CoA Reductase 100% .000085uM NoneNone View
3-hydroxy-3-methylglutaryl-Coenzyme A reductase CERIVASTATIN HMG-CoA Reductase 100% .000085uM NoneNone View
prostaglandin-endoperoxide synthase 1 CELECOXIB Cyclooxygenase COX-1 100% .723uM NoneNone View
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) CELECOXIB Cyclooxygenase COX-1 100% .723uM NoneNone View
Cytochrom P450-1A2 monooxygenase PHENOTHIAZINE CYP450-1A2 Inhibition 100% .016uM NoneNone View
prostaglandin-endoperoxide synthase 2 CELECOXIB Cyclooxygenase COX-2 100% .484uM NoneNone View
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) CELECOXIB Cyclooxygenase COX-2 100% .484uM NoneNone View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 CELECOXIB Dopamine Transporter 100% 2.431uM 1.931uM View
prostaglandin-endoperoxide synthase 1 PHENOTHIAZINE Cyclooxygenase COX-1 100% .196uM NoneNone View
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) PHENOTHIAZINE Cyclooxygenase COX-1 100% .196uM NoneNone View
arachidonate 15-lipoxygenase, second type PHENOTHIAZINE Lipoxygenase 15-LO 100% 4.643uM NoneNone View
arachidonate 15-lipoxygenase PHENOTHIAZINE Lipoxygenase 15-LO 100% 4.643uM NoneNone View
sodium channel, voltage-gated, type VII, alpha DANAZOL Sodium Channel, Site 2 100% 2.978uM 2.67uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) DANAZOL Sodium Channel, Site 2 100% 2.978uM 2.67uM View
sodium channel, voltage-gated, type IV, beta DANAZOL Sodium Channel, Site 2 100% 2.978uM 2.67uM View
sodium channel, voltage-gated, type IV, alpha DANAZOL Sodium Channel, Site 2 100% 2.978uM 2.67uM View
sodium channel, nonvoltage-gated 1, delta BETA-ESTRADIOL 3-BENZOATE Sodium Channel, Site 2 100% 3.278uM 2.939uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) BETA-ESTRADIOL 3-BENZOATE Sodium Channel, Site 2 100% 3.278uM 2.939uM View
sodium channel, nonvoltage-gated 1 alpha BETA-ESTRADIOL 3-BENZOATE Sodium Channel, Site 2 100% 3.278uM 2.939uM View
sodium channel, voltage-gated, type X, alpha BETA-ESTRADIOL 3-BENZOATE Sodium Channel, Site 2 100% 3.278uM 2.939uM View
sodium channel, voltage-gated, type IX, alpha BETA-ESTRADIOL 3-BENZOATE Sodium Channel, Site 2 100% 3.278uM 2.939uM View
sodium channel, voltage gated, type VIII, alpha BETA-ESTRADIOL 3-BENZOATE Sodium Channel, Site 2 100% 3.278uM 2.939uM View
sodium channel, voltage-gated, type VII, alpha BETA-ESTRADIOL 3-BENZOATE Sodium Channel, Site 2 100% 3.278uM 2.939uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) BETA-ESTRADIOL 3-BENZOATE Sodium Channel, Site 2 100% 3.278uM 2.939uM View
sodium channel, voltage-gated, type IV, beta BETA-ESTRADIOL 3-BENZOATE Sodium Channel, Site 2 100% 3.278uM 2.939uM View
sodium channel, voltage-gated, type IV, alpha BETA-ESTRADIOL 3-BENZOATE Sodium Channel, Site 2 100% 3.278uM 2.939uM View
mu-opioid receptor MOR MEPAZINE Opiate mu 16% NoneNone NoneNone View
sodium channel, voltage-gated, type III, alpha BETA-ESTRADIOL 3-BENZOATE Sodium Channel, Site 2 100% 3.278uM 2.939uM View
sodium channel, voltage-gated, type II, beta BETA-ESTRADIOL 3-BENZOATE Sodium Channel, Site 2 100% 3.278uM 2.939uM View
sodium channel, voltage-gated, type II, alpha 2 BETA-ESTRADIOL 3-BENZOATE Sodium Channel, Site 2 100% 3.278uM 2.939uM View
sodium channel, voltage-gated, type I, beta BETA-ESTRADIOL 3-BENZOATE Sodium Channel, Site 2 100% 3.278uM 2.939uM View
sodium channel, voltage-gated, type I, alpha BETA-ESTRADIOL 3-BENZOATE Sodium Channel, Site 2 100% 3.278uM 2.939uM View
androgen receptor TESTOSTERONE Testosterone 100% .006169uM .004112uM View
progesterone receptor PROGESTERONE Progesterone 100% .028uM .003622uM View
progesterone receptor PROGESTERONE Progesterone 100% .028uM .003622uM View
mitogen activated protein kinase 14 LIPOPOLYSACCHARIDE E. COLI O55:B5 Protein Serine/Threonine Kinase, p38alpha 100% .0606uM NoneNone View
mitogen-activated protein kinase 14 LIPOPOLYSACCHARIDE E. COLI O55:B5 Protein Serine/Threonine Kinase, p38alpha 100% .0606uM NoneNone View
epidermal growth factor receptor LIPOPOLYSACCHARIDE E. COLI O55:B5 Protein Tyrosine Kinase, EGF Receptor 100% .188uM NoneNone View
Protein-tyrosine kinase, Fyn LIPOPOLYSACCHARIDE E. COLI O55:B5 Protein Tyrosine Kinase, Fyn 100% .1909uM NoneNone View
arachidonate 15-lipoxygenase, second type 4-OCTYLPHENOL Lipoxygenase 15-LO 100% 4.093uM NoneNone View
arachidonate 15-lipoxygenase 4-OCTYLPHENOL Lipoxygenase 15-LO 100% 4.093uM NoneNone View
arachidonate 15-lipoxygenase 4-OCTYLPHENOL Lipoxygenase 15-LO 100% 4.093uM NoneNone View
estrogen receptor 1 MESTRANOL Estrogen ERalpha 100% .018uM .005223uM View
estrogen receptor 1 MESTRANOL Estrogen ERalpha 100% .018uM .005223uM View
adrenergic receptor, alpha 2b 4-OCTYLPHENOL Adrenergic alpha2B 100% 12.496uM 5.705uM View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) LIPOPOLYSACCHARIDE E. COLI O55:B5 Protein Tyrosine Kinase, HER2 Receptor 100% .4493uM NoneNone View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) LIPOPOLYSACCHARIDE E. COLI O55:B5 Protein Tyrosine Kinase, HER2 Receptor 100% .4493uM NoneNone View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 ALPRAZOLAM GABAA, Benzodiazepine, Central 100% .0166uM .0135uM View
gamma-aminobutyric acid A receptor, gamma 1 ALPRAZOLAM GABAA, Benzodiazepine, Central 100% .0166uM .0135uM View
gamma-aminobutyric acid A receptor, pi ALPRAZOLAM GABAA, Benzodiazepine, Central 100% .0166uM .0135uM View
AT hook, DNA binding motif, containing 1 (DBSS) ALPRAZOLAM GABAA, Benzodiazepine, Central 100% .0166uM .0135uM View
gamma-aminobutyric acid A receptor, theta ALPRAZOLAM GABAA, Benzodiazepine, Central 100% .0166uM .0135uM View
gamma-aminobutyric acid A receptor, gamma 2 ALPRAZOLAM GABAA, Benzodiazepine, Central 100% .0166uM .0135uM View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 ALPRAZOLAM GABAA, Benzodiazepine, Central 100% .0166uM .0135uM View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 ALPRAZOLAM GABAA, Benzodiazepine, Central 100% .0166uM .0135uM View
gamma-aminobutyric acid A receptor, alpha 2 ALPRAZOLAM GABAA, Benzodiazepine, Central 100% .0166uM .0135uM View
gamma-aminobutyric acid A receptor, alpha 1 ALPRAZOLAM GABAA, Benzodiazepine, Central 100% .0166uM .0135uM View
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 ALPRAZOLAM GABAA, Benzodiazepine, Central 100% .0166uM .0135uM View
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 ALPRAZOLAM GABAA, Benzodiazepine, Central 100% .0166uM .0135uM View
gamma-aminobutyric acid A receptor, delta ALPRAZOLAM GABAA, Benzodiazepine, Central 100% .0166uM .0135uM View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 ALPRAZOLAM GABAA, Benzodiazepine, Central 100% .0166uM .0135uM View
prostaglandin-endoperoxide synthase 1 KETOROLAC Cyclooxygenase COX-1 100% .013uM NoneNone View
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) KETOROLAC Cyclooxygenase COX-1 100% .013uM NoneNone View
sodium channel associated protein 1 PROCHLORPERAZINE Sodium Channel, Site 2 100% 1.265uM 1.154uM View
sodium channel associated protein 2 PROCHLORPERAZINE Sodium Channel, Site 2 100% 1.265uM 1.154uM View
sodium channel, voltage-gated, type III, beta PROCHLORPERAZINE Sodium Channel, Site 2 100% 1.265uM 1.154uM View
sodium channel, voltage-gated, type I, alpha PROCHLORPERAZINE Sodium Channel, Site 2 100% 1.265uM 1.154uM View
sodium channel, voltage-gated, type IX, alpha PROCHLORPERAZINE Sodium Channel, Site 2 100% 1.265uM 1.154uM View
sodium channel, voltage-gated, type VII, alpha PROCHLORPERAZINE Sodium Channel, Site 2 100% 1.265uM 1.154uM View
A3 adenosine receptor ISOTRETINOIN Adenosine A3 74% 4.169uM 2.357uM View
amiloride-sensitive cation channel 5, intestinal PROCHLORPERAZINE Sodium Channel, Site 2 100% 1.265uM 1.154uM View
sodium channel, voltage-gated, type III, beta PROCHLORPERAZINE Sodium Channel, Site 2 100% 1.265uM 1.154uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide PROCHLORPERAZINE Sodium Channel, Site 2 100% 1.265uM 1.154uM View
sodium channel, voltage-gated, type XI, alpha PROCHLORPERAZINE Sodium Channel, Site 2 100% 1.265uM 1.154uM View
sodium channel, voltage-gated, type I, beta PROCHLORPERAZINE Sodium Channel, Site 2 100% 1.265uM 1.154uM View
sodium channel, voltage-gated, type 10, alpha polypeptide PROCHLORPERAZINE Sodium Channel, Site 2 100% 1.265uM 1.154uM View
sodium channel, voltage-gated, type IV, alpha polypeptide PROCHLORPERAZINE Sodium Channel, Site 2 100% 1.265uM 1.154uM View
sodium channel, voltage-gated, type V, alpha polypeptide PROCHLORPERAZINE Sodium Channel, Site 2 100% 1.265uM 1.154uM View
sodium channel, voltage-gated, type II, beta PROCHLORPERAZINE Sodium Channel, Site 2 100% 1.265uM 1.154uM View
sodium channel, nonvoltage-gated 1 alpha PROCHLORPERAZINE Sodium Channel, Site 2 100% 1.265uM 1.154uM View
sodium channel, nonvoltage-gated 1 gamma PROCHLORPERAZINE Sodium Channel, Site 2 100% 1.265uM 1.154uM View
sodium channel, nonvoltage-gated 1 beta PROCHLORPERAZINE Sodium Channel, Site 2 100% 1.265uM 1.154uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide PROCHLORPERAZINE Sodium Channel, Site 2 100% 1.265uM 1.154uM View
sodium channel, voltage-gated, type XI, alpha PROCHLORPERAZINE Sodium Channel, Site 2 100% 1.265uM 1.154uM View
sodium channel, nonvoltage-gated 1, gamma PROCHLORPERAZINE Sodium Channel, Site 2 100% 1.265uM 1.154uM View
sodium channel, nonvoltage-gated 1, delta PROCHLORPERAZINE Sodium Channel, Site 2 100% 1.265uM 1.154uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) PROCHLORPERAZINE Sodium Channel, Site 2 100% 1.265uM 1.154uM View
sodium channel, nonvoltage-gated 1 alpha PROCHLORPERAZINE Sodium Channel, Site 2 100% 1.265uM 1.154uM View
sodium channel, voltage-gated, type III, alpha MICONAZOLE Sodium Channel, Site 2 100% 3.065uM 2.748uM View
sodium channel, voltage-gated, type II, beta MICONAZOLE Sodium Channel, Site 2 100% 3.065uM 2.748uM View
sodium channel, voltage-gated, type II, alpha 2 MICONAZOLE Sodium Channel, Site 2 100% 3.065uM 2.748uM View
sodium channel, voltage-gated, type I, beta MICONAZOLE Sodium Channel, Site 2 100% 3.065uM 2.748uM View
sodium channel, voltage-gated, type I, alpha MICONAZOLE Sodium Channel, Site 2 100% 3.065uM 2.748uM View
Cytochrom P450-1A2 monooxygenase METHOXSALEN CYP450-1A2 Inhibition 100% .04uM NoneNone View
dopamine receptor 2 MICONAZOLE Dopamine D2L 100% 12.504uM 4.168uM View
dopamine receptor D3 MICONAZOLE Dopamine D3 100% 3.199uM 1.086uM View
cholinergic receptor, muscarinic 4 MICONAZOLE Muscarinic M4 100% 3.197uM .446uM View
adrenergic receptor, alpha 2b MICONAZOLE Adrenergic alpha2B 100% 3.598uM 1.642uM View